Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Priority Review for Eagle Pharmaceuticals’ Ryanodex NDA for the Treatment of Exertional H

americanpharmaceuticalreviewMarch 28, 2017

Tag: FDA , Eagle

PharmaSources Customer Service